- JP-listed companies
- HABA LABORATORIES, INC.
- Income statement
HABA LABORATORIES, INC.JP:4925
Market cap
¥6.6B
P/E ratio
13.2x
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 13,579 | 13,234 | 13,787 | 13,181 | 14,811 | 16,136 | 17,886 | 19,254 | 18,370 | 14,308 | 12,909 | 12,038 | 12,324 | 12,062 |
| Cost of revenue | - | - | - | 3,205 | 3,628 | 4,023 | 4,547 | 4,741 | 4,705 | 4,108 | 4,114 | 3,870 | 3,921 | 3,969 |
| Gross profit | - | - | - | 9,976 | 11,183 | 12,113 | 13,339 | 14,513 | 13,664 | 10,200 | 8,795 | 8,169 | 8,404 | 8,093 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating income | - | - | - | 283 | 1,525 | 1,770 | 2,400 | 3,095 | 1,998 | 227 | -317 | -610 | -188 | 590 |
| Operating expenses | - | - | - | 9,693 | 9,658 | 10,343 | 10,939 | 11,418 | 11,666 | 9,973 | 9,112 | 8,778 | 8,591 | 7,503 |
| Income before tax | 1,000 | 400 | 1,208 | 244 | 1,537 | 1,748 | 2,390 | 3,101 | 1,976 | 251 | -293 | -583 | -191 | 609 |
| Provision for income taxes | - | - | - | 195 | 684 | 531 | 783 | 985 | 614 | 68 | 2 | 159 | 275 | 59 |
| Net income | 286 | -63 | 838 | 45 | 982 | 1,214 | 1,598 | 2,088 | 1,313 | 216 | -269 | -708 | -2,119 | 577 |
| Earnings per share | 136.72 | 2.55 | 232.94 | 11.39 | 249.73 | 308.51 | 406.2 | 530.93 | 339.36 | 57.23 | -71.14 | -187.19 | -560.26 | 152.47 |
| Dividend per share | 20 | 20 | 20 | 20 | 20 | 30 | 30 | 40 | 40 | 40 | 40 | 40 | 40 | 40 |